INKT Historical Earnings image   This INKT historical earnings page last updated 11/7/2022
INKT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022NA
Q2 20228/9/2022NA
Q1 20225/10/2022NA
Q4 20213/18/2022NA
INKT Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022-0.190
Q2 20228/9/2022-0.180
Q1 20225/10/2022-0.230
Q4 20213/18/2022-0.180
What was the record high INKT historical earnings result?
In terms of earnings or revenue, what is the best INKT historical earnings result that MiNK Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest INKT historical earnings result was set in Q2 2022, when MiNK Therapeutics posted results of -0.180/share. The most successful revenue quarter within our data set was Q3 2022 when MiNK Therapeutics reported revenue of NA.

What was the lowest MiNK Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest INKT has reported, and when?

✔️Accepted answer: Within our data set, the lowest INKT historical earnings result was set in Q1 2022, when MiNK Therapeutics posted results of -0.230/share. The smallest revenue quarter within our data set was Q3 2022 when MiNK Therapeutics reported revenue of NA.

On this page we presented the INKT historical earnings date information for MiNK Therapeutics. Reviewing that INKT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2022, when INKT posted gaap of -0.180/share. Meanwhile the lowest INKT historical earnings result was in Q1 2022, when INKT posted gaap of -0.230/share. Moving to MiNK Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2022 when INKT reported NA in revenue, while the smallest revenue quarter was Q3 2022 when INKT reported NA in revenue.

For self directed investors doing their due diligence on INKT or any other given stock, their research can benefit from looking into all of the MiNK Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into MiNK Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for INKT. Thanks for visiting, and the next time you need to research INKT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: CNYA Videos, BVAL Videos, FLKM Options Chain.

 

INKT Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.